ArticleEJHaem2026

Comparison of Venetoclax-Based Treatments for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia: A Single-Center Real-World Experience.

Benjamin Heyman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.